Abstract
Background: Pulmonary embolism (PE) occurs in one-third of critically-ill COVID-19 patients. Although prior studies identified several pathways contributing to thrombogenicity, it is unknown whether this is COVID-19-specific or also occurs in ARDS patients with another infection. Objective: To compare pathway activity among patients having COVID-19 with PE (C19PE+), COVID-19 without
... read more